CorTec, Heraeus Medevio Enter Strategic Partnership

Heraeus Medevio, a full-service contract design, development, and manufacturing partner to medical device companies around the world, announced a strategic partnership with CorTec GmbH, a leader in innovative implantable technologies based in Freiburg, Baden-Wuerttemberg, Germany.

The partnership will combine CorTec’s expertise in the development, rapid prototyping, and small series production of nerve cuff and paddle electrodes, capable of sensing and stimulation, with Heraeus Medevio’s advanced capabilities in scaling and design for manufacturing to bring medical devices to the market faster.

This collaboration addresses the neuromodulation market’s growing demand for innovative, high-quality implantable components. Together, the companies will deliver next-generation neuromodulation devices and drive global innovation as strategic partners with a shared commitment to world-class quality and continuous improvement.  

CorTec’s CEO, Dr. Oliver Baertl, commented, “Partnering with Heraeus Medevio marks a decisive step in our mission to make the impossible possible for our customers. This cooperation allows Heraeus Medevio and us to combine our strengths. We can now ensure that our customers, regardless of size and location, have access to a complete suite of implantable solutions from prototype to large-scale production, all backed by the highest standards of quality and support.”

“We are thrilled to partner with a company as innovative and driven as CorTec,” said Toiné Warren, Executive Vice President, Commercial at Heraeus Medevio. “It is an opportunity to leverage each other’s expertise to provide a wider breadth of offerings to meet our customers’ needs in the neuromodulation space. This partnership with CorTec, to exclusively manufacture their products to ramp and scale, positions us to bring forth the future of implantable technologies for our customers, driving our vision to improve 100 million lives every year forward.”

Heraeus Medevio’s high-volume manufacturing of the cuff and paddle electrodes for the neuromodulation sector, based on CorTec’s proprietary laser-micromachining technology, is expected to begin by the end of 2025.